152 related articles for article (PubMed ID: 23275176)
1. Regulation of neural progenitor cell proliferation by D609: potential role for ERK.
Kalluri HS; Gusain A; Dempsey RJ
Mol Neurobiol; 2013 Apr; 47(2):782-9. PubMed ID: 23275176
[TBL] [Abstract][Full Text] [Related]
2. D609-mediated inhibition of ATP synthesis in neural progenitor cells.
Kalluri HS; Dempsey RJ
Neuroreport; 2014 Jul; 25(10):777-81. PubMed ID: 24918458
[TBL] [Abstract][Full Text] [Related]
3. D609 inhibits the proliferation of neural progenitor cells.
Kalluri HS; Dempsey RJ
Neuroreport; 2010 Jul; 21(10):700-3. PubMed ID: 20568314
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
5. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.
Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726
[TBL] [Abstract][Full Text] [Related]
6. D609 blocks cell survival and induces apoptosis in neural stem cells.
Wang N; Lv X; Su L; Zhao B; Zhang S; Miao J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4780-3. PubMed ID: 16872828
[TBL] [Abstract][Full Text] [Related]
7. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
8. Protection by D609 through cell-cycle regulation after stroke.
Adibhatla RM; Hatcher JF
Mol Neurobiol; 2010 Jun; 41(2-3):206-17. PubMed ID: 20148315
[TBL] [Abstract][Full Text] [Related]
9. Chronic D609 treatment interferes with cell cycle and targets the expression of Olig2 in Glioma Stem like Cells.
Kalluri HSG; Kuo JS; Dempsey RJ
Eur J Pharmacol; 2017 Nov; 814():81-86. PubMed ID: 28802717
[TBL] [Abstract][Full Text] [Related]
10. The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes.
Milhas D; Andrieu-Abadie N; Levade T; Benoist H; Ségui B
Int J Mol Sci; 2012; 13(7):8834-8852. PubMed ID: 22942738
[TBL] [Abstract][Full Text] [Related]
11. Effect of D609 on the expression of GADD45β protein: Potential inhibitory role in the growth of glioblastoma cancer stem like cells.
Kalluri HSG; Kuo JS; Dempsey RJ
Eur J Pharmacol; 2016 Nov; 791():510-517. PubMed ID: 27658347
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells.
Kahle PJ; Shooter EM; Johnson RM; Verity AN
Cell Signal; 1998 May; 10(5):321-30. PubMed ID: 9692675
[TBL] [Abstract][Full Text] [Related]
13. The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609.
Perry RJ; Ridgway ND
J Lipid Res; 2004 Jan; 45(1):164-73. PubMed ID: 13130125
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Singh AT; Radeff JM; Kunnel JG; Stern PH
Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
Kiss Z; Crilly KS; Chung T
Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
17. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
[TBL] [Abstract][Full Text] [Related]
18. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation.
Walro DG; Rosenthal KS
Antiviral Res; 1997 Sep; 36(1):63-72. PubMed ID: 9330762
[TBL] [Abstract][Full Text] [Related]
19. A novel role of the antitumor agent tricyclodecan-9-yl-xanthogenate as an open channel blocker of KCNQ1/KCNE1.
Wu M; Takemoto M; Luo H; Xu JJ; Lu MH; Kameyama M; Takumi T; Song WJ
Eur J Pharmacol; 2018 Apr; 824():99-107. PubMed ID: 29438706
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PC-PLC blocked the survival of mouse neural cells by up-regulating the expression of integrin beta4 and Rb.
Lv X; Wang N; Su L; Zhang S; Miao J
Dev Neurosci; 2006; 28(6):499-504. PubMed ID: 17028427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
